$MRNA “Stock Sumo” Promoter Rank: 16/25 Moderna, Inc. Newsletter 7:03:27 AM August 4, 2022

on August 4, 2022 Newsletters and Tags: , , , , , , , , , , with 0 comments
Time:
7:03 AM (CST)
Date:
August 4, 2022
Symbol:
MRNA
Company:
Moderna, Inc.
Stock promoter:
Stock Sumo
Stock promoter rank:
16 out of 25
Read more

$MRNA Moderna Announces New Supply Contract With The U.S. Government For An Initial 66 Million Doses Of A Moderna Bivalent Covid-19 Booster Vaccine With Options For U.S. Government To Purchase Up To An Additional 234 Million Doses

on July 29, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in Adolescents (12-17 Years) in the European Union

on July 22, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

on July 19, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNA
Source:
ACN Newswire
Read more

$MRNA Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six Months to Five Years

on July 18, 2022 News and Tags: , , , with 0 comments
Time:
11:00 PM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Health Canada Authorizes Moderna’s COVID-19 Vaccine in Young Children (6 Months-5 Years)

on July 14, 2022 News and Tags: , , , with 0 comments
Time:
11:30 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna to Report First Quarter Financial Results on Wednesday, August 3, 2022

on July 13, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna Announces First Participant Dosed in a Phase 1 Trial of its Nipah Virus mRNA Vaccine, mRNA-1215

on July 12, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna’s Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster

on July 11, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna Announces Bivalent Booster mRNA-1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants BA.4 And BA.5

on June 22, 2022 News and Tags: , , , with 0 comments
Time:
7:03 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom

on June 21, 2022 News and Tags: , , , with 0 comments
Time:
7:05 PM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna Receives FDA Authorization for Emergency Use of Its COVID-19 Vaccine for Children 6 Months of Age and Older

on June 17, 2022 News and Tags: , , , with 0 comments
Time:
9:05 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron

on June 8, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna Announces First Participants Dosed in Phase 3 Study of Seasonal Influenza Vaccine Candidate (mRNA-1010)

on June 7, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement

on June 2, 2022 News and Tags: , , , with 0 comments
Time:
6:30 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna to Present at Upcoming Conferences in June 2022

on June 1, 2022 News and Tags: , , , with 0 comments
Time:
7:57 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna

on May 31, 2022 News and Tags: , , , , , , , with 0 comments
Time:
3:56 AM
Symbol:
MRNA
Source:
Business Wire
Read more

$MRNA Moderna and Takeda Announce Plans to Transfer Marketing Authorization for Spikevax(TM) COVID-19 Vaccine in Japan to Moderna

on May 31, 2022 News and Tags: , , , , , , , with 0 comments
Time:
3:40 AM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA Moderna to Present at the UBS 2022 Global Healthcare Conference

on May 18, 2022 News and Tags: , , , with 0 comments
Time:
3:55 PM
Symbol:
MRNA
Source:
AccessWire
Read more

$MRNA IAVI and Moderna Launch First-in-Africa Clinical Trial of mRNA HIV Vaccine Development Program

on May 18, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNA
Source:
AccessWire
Read more